Aspira Price To Sales Ratio vs Capex To Depreciation Analysis

AWH Stock

USD 0.81 0.05 6.58%

Aspira Womens financial indicator trend analysis is way more than just evaluating Aspira Womens Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aspira Womens Health is a good investment. Please check the relationship between Aspira Womens Price To Sales Ratio and its Capex To Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aspira Womens Health Price To Sales Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have very week relationship.

The correlation between Aspira Womens' Price To Sales Ratio and Capex To Depreciation is 0.2. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Aspira Womens Health, assuming nothing else is changed. The correlation between historical values of Aspira Womens' Price To Sales Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Aspira Womens Health are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Price To Sales Ratio i.e., Aspira Womens' Price To Sales Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.2

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Aspira Womens Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aspira Womens sales, a figure that is much harder to manipulate than other Aspira Womens Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Aspira Womens' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aspira Womens Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

The current Selling General Administrative is estimated to decrease to about 11.5 M. The current Issuance Of Capital Stock is estimated to decrease to about 191.9 K

	2021	2022	2023	2024 (projected)
Total Operating Expenses	35.7M	37.1M	24.1M	20.9M
Cost Of Revenue	3.8M	3.9M	3.9M	3.4M

Total Operating Expenses Cost Of Revenue

Aspira Womens fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Property Plant And Equipment Gross	Short Term Debt	Intangible Assets
Total Assets		0.85	-0.97	0.99	0.2	0.99	-0.11	0.21	-0.05	1.0	0.12	0.5	0.46	-0.17	-0.03	0.23	-0.2	-0.01	-0.22	-0.06	-0.09	-0.17	0.0	0.47	0.12	-0.18
Total Stockholder Equity	0.85		-0.88	0.88	0.3	0.88	-0.02	0.53	-0.55	0.88	0.21	0.34	0.24	-0.1	-0.34	0.13	-0.39	-0.36	-0.37	0.05	-0.17	-0.61	-0.05	0.38	0.21	0.11
Net Debt	-0.97	-0.88		-0.98	-0.29	-0.98	0.25	-0.14	0.15	-0.97	-0.19	-0.32	-0.29	0.17	-0.07	-0.08	0.24	0.09	0.35	0.19	0.29	0.21	0.17	-0.41	-0.19	0.26
Cash	0.99	0.88	-0.98		0.29	1.0	-0.18	0.2	-0.11	1.0	0.12	0.43	0.45	-0.21	-0.01	0.18	-0.28	-0.1	-0.31	-0.13	-0.17	-0.24	-0.08	0.41	0.12	-0.22
Other Assets	0.2	0.3	-0.29	0.29		0.29	-0.64	-0.16	-0.28	0.23	-0.19	-0.31	0.12	-0.3	0.28	-0.33	-0.46	-0.41	-0.63	-0.66	-0.51	-0.3	-0.54	-0.31	-0.19	-0.58
Cash And Short Term Investments	0.99	0.88	-0.98	1.0	0.29		-0.18	0.2	-0.11	1.0	0.12	0.43	0.45	-0.21	-0.01	0.18	-0.28	-0.1	-0.31	-0.13	-0.17	-0.24	-0.08	0.41	0.12	-0.22
Common Stock Shares Outstanding	-0.11	-0.02	0.25	-0.18	-0.64	-0.18		0.64	-0.02	-0.09	-0.12	0.54	0.19	0.08	-0.83	0.61	0.06	0.32	0.8	0.99	0.83	-0.1	0.9	0.23	-0.12	0.82
Other Stockholder Equity	0.21	0.53	-0.14	0.2	-0.16	0.2	0.64		-0.66	0.27	0.02	0.45	0.17	0.04	-0.93	0.32	-0.3	-0.25	0.1	0.67	0.48	-0.67	0.47	0.23	0.02	0.75
Total Liab	-0.05	-0.55	0.15	-0.11	-0.28	-0.11	-0.02	-0.66		-0.11	-0.22	0.19	0.32	-0.09	0.52	0.22	0.39	0.69	0.47	-0.09	0.24	0.87	0.18	0.03	-0.22	-0.42
Total Current Assets	1.0	0.88	-0.97	1.0	0.23	1.0	-0.09	0.27	-0.11		0.1	0.49	0.48	-0.21	-0.09	0.24	-0.28	-0.06	-0.23	-0.03	-0.08	-0.25	0.0	0.44	0.1	-0.15
Short Long Term Debt Total	0.12	0.21	-0.19	0.12	-0.19	0.12	-0.12	0.02	-0.22	0.1		0.01	-0.17	0.43	0.03	-0.02	0.32	-0.1	-0.3	-0.11	-0.32	-0.12	-0.15	0.18	1.0	0.23
Other Current Liab	0.5	0.34	-0.32	0.43	-0.31	0.43	0.54	0.45	0.19	0.49	0.01		0.6	0.12	-0.47	0.57	0.13	0.3	0.34	0.51	0.67	0.02	0.68	0.57	0.01	0.36
Total Current Liabilities	0.46	0.24	-0.29	0.45	0.12	0.45	0.19	0.17	0.32	0.48	-0.17	0.6		-0.38	-0.2	0.68	-0.34	0.07	0.15	0.14	0.37	-0.07	0.34	0.07	-0.17	-0.03
Property Plant And Equipment Net	-0.17	-0.1	0.17	-0.21	-0.3	-0.21	0.08	0.04	-0.09	-0.21	0.43	0.12	-0.38		-0.03	-0.04	0.85	-0.11	-0.12	0.09	0.05	0.04	0.03	0.57	0.42	0.4
Retained Earnings	-0.03	-0.34	-0.07	-0.01	0.28	-0.01	-0.83	-0.93	0.52	-0.09	0.03	-0.47	-0.2	-0.03		-0.46	0.25	0.11	-0.37	-0.83	-0.63	0.57	-0.66	-0.17	0.03	-0.86
Accounts Payable	0.23	0.13	-0.08	0.18	-0.33	0.18	0.61	0.32	0.22	0.24	-0.02	0.57	0.68	-0.04	-0.46		-0.04	0.14	0.49	0.59	0.42	-0.1	0.61	0.32	-0.02	0.44
Non Current Assets Total	-0.2	-0.39	0.24	-0.28	-0.46	-0.28	0.06	-0.3	0.39	-0.28	0.32	0.13	-0.34	0.85	0.25	-0.04		0.35	0.14	0.03	0.13	0.54	0.08	0.52	0.31	0.14
Non Currrent Assets Other	-0.01	-0.36	0.09	-0.1	-0.41	-0.1	0.32	-0.25	0.69	-0.06	-0.1	0.3	0.07	-0.11	0.11	0.14	0.35		0.67	0.24	0.47	0.83	0.38	0.11	-0.1	-0.11
Net Receivables	-0.22	-0.37	0.35	-0.31	-0.63	-0.31	0.8	0.1	0.47	-0.23	-0.3	0.34	0.15	-0.12	-0.37	0.49	0.14	0.67		0.76	0.73	0.41	0.79	0.03	-0.3	0.4
Common Stock Total Equity	-0.06	0.05	0.19	-0.13	-0.66	-0.13	0.99	0.67	-0.09	-0.03	-0.11	0.51	0.14	0.09	-0.83	0.59	0.03	0.24	0.76		0.77	-0.17	0.88	0.23	-0.11	0.83
Non Current Liabilities Total	-0.09	-0.17	0.29	-0.17	-0.51	-0.17	0.83	0.48	0.24	-0.08	-0.32	0.67	0.37	0.05	-0.63	0.42	0.13	0.47	0.73	0.77		0.15	0.84	0.2	-0.33	0.55
Inventory	-0.17	-0.61	0.21	-0.24	-0.3	-0.24	-0.1	-0.67	0.87	-0.25	-0.12	0.02	-0.07	0.04	0.57	-0.1	0.54	0.83	0.41	-0.17	0.15		0.01	0.03	-0.12	-0.43
Other Current Assets	0.0	-0.05	0.17	-0.08	-0.54	-0.08	0.9	0.47	0.18	0.0	-0.15	0.68	0.34	0.03	-0.66	0.61	0.08	0.38	0.79	0.88	0.84	0.01		0.21	-0.15	0.61
Property Plant And Equipment Gross	0.47	0.38	-0.41	0.41	-0.31	0.41	0.23	0.23	0.03	0.44	0.18	0.57	0.07	0.57	-0.17	0.32	0.52	0.11	0.03	0.23	0.2	0.03	0.21		0.18	0.31
Short Term Debt	0.12	0.21	-0.19	0.12	-0.19	0.12	-0.12	0.02	-0.22	0.1	1.0	0.01	-0.17	0.42	0.03	-0.02	0.31	-0.1	-0.3	-0.11	-0.33	-0.12	-0.15	0.18		0.23
Intangible Assets	-0.18	0.11	0.26	-0.22	-0.58	-0.22	0.82	0.75	-0.42	-0.15	0.23	0.36	-0.03	0.4	-0.86	0.44	0.14	-0.11	0.4	0.83	0.55	-0.43	0.61	0.31	0.23

Click cells to compare fundamentals

Aspira Womens Account Relationship Matchups

Aspira Womens fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	13.8M	19.6M	41.1M	17.4M	6.3M	5.9M
Total Stockholder Equity	8.7M	9.7M	30.2M	6.7M	(2.4M)	(2.2M)
Net Debt	(10.4M)	(11.5M)	(33.1M)	(9.5M)	255K	267.8K
Cash	11.7M	16.6M	37.2M	13.3M	2.6M	2.5M
Other Assets	65K	419.0	264K	414K	1.0	0.95
Cash And Short Term Investments	11.7M	16.6M	37.2M	13.3M	2.6M	2.5M
Common Stock Shares Outstanding	5.8M	6.7M	7.4M	7.8M	9.2M	9.7M
Liabilities And Stockholders Equity	13.8M	19.6M	41.1M	17.4M	6.3M	5.9M
Other Stockholder Equity	430.8M	449.7M	501.8M	505.5M	515.9M	326.2M
Total Liab	5.1M	9.9M	10.9M	10.6M	8.6M	14.1M
Total Current Assets	13.4M	18.6M	40.0M	16.3M	5.3M	5.0M
Short Long Term Debt Total	1.3M	5.1M	4.1M	3.8M	2.9M	2.7M
Other Current Liab	39K	4.0M	5.3M	3.7M	2.9M	2.7M
Total Current Liabilities	4.0M	6.4M	7.8M	5.8M	5.1M	6.0M
Property Plant And Equipment Net	353K	989K	810K	650K	693K	658.4K
Retained Earnings	(422.2M)	(440.1M)	(471.7M)	(498.9M)	(518.3M)	(492.4M)
Accounts Payable	950K	1.2M	1.1M	1.5M	1.3M	1.5M
Non Current Assets Total	418K	1.0M	1.1M	1.1M	982K	932.9K
Non Currrent Assets Other	65K	13K	264K	414K	289K	274.6K
Net Receivables	924K	865K	1.0M	1.2M	1.5M	2.0M
Common Stock Total Equity	60K	75K	97K	105K	120.8K	126.8K
Non Current Liabilities Total	1.1M	3.5M	3.1M	4.9M	3.5M	3.3M
Inventory	25K	30K	174K	316K	227K	215.7K
Other Current Assets	758K	2.2M	1.6M	1.4M	2.0M	2.1M
Property Plant And Equipment Gross	353K	989K	3.6M	650K	585K	555.8K
Short Term Debt	193K	1.3M	1.0M	1.2M	995K	945.3K
Common Stock	97K	105K	112K	125K	11K	10.5K
Long Term Debt	1.1M	3.1M	2.7M	2.3M	2.1M	2.0M
Short Long Term Debt	193K	1.6M	980K	1.2M	1.1M	997.8K
Net Tangible Assets	8.7M	9.7M	30.2M	6.7M	6.1M	5.8M
Long Term Debt Total	1.5M	1.3M	1.1M	3.1M	3.5M	3.7M
Capital Surpluse	399.4M	414.0M	430.8M	449.7M	517.1M	453.1M
Property Plant Equipment	353K	989K	810K	650K	585K	800.6K

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:

How To Invest In Aspira

Details

Is Aspira Stock a good investment?

Details

What is Aspira Womens' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.15)

Revenue Per Share

0.801

Quarterly Revenue Growth

(0.03)

Return On Assets

(1.86)

Return On Equity

(7.23)

The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aspira Price To Sales Ratio vs Capex To Depreciation Analysis

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Capex To Depreciation

Aspira Womens fundamental ratios Correlations

Aspira Womens Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aspira Womens fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Short Term Debt	+ 1.0	Short Long Term Debt Total
Cash	+ 0.99	Total Assets

Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Total Current Assets	- 0.97	Net Debt
Net Debt	- 0.97	Total Assets
Retained Earnings	- 0.93	Other Stockholder Equity
Net Debt	- 0.88	Total Stockholder Equity